John Wiley & Sons, Ltd.

Environmental risk assessment of human pharmaceuticals: Regulatory developments

Concern about the potential environmental impact of pharmaceutical residues in the aquatic environment was first expressed over 30 years ago. It is therefore surprising that there is still so little current regulation requiring environmental risk assessments to be undertaken on human pharmaceuticals. Particularly in view of the rapid development in legislation, that has taken place in many parts of the world during this period, requiring environmental risk assessments for industrial chemicals, agrochemicals and biocides. This review examines the existing regulations together with proposals being considered elsewhere. It identifies problems and inconsistencies and makes recommendations for changes that might produce a more effective and efficient system. This article is protected by copyright. All rights reserved

Customer comments

No comments were found for Environmental risk assessment of human pharmaceuticals: Regulatory developments. Be the first to comment!